蛋白质组学研究及其在肿瘤诊断和治疗中的应用
被引量:3
Proteomics and application in tumor diagnosis and treatment
摘要
蛋白质组学是研究蛋白质组成和动态变化的一门新兴学科 ,蛋白质组学研究技术的主要步骤包括样品制备、双向凝胶电泳 (2 DE)、蛋白质的鉴定技术及相应的信息技术和数据库 4大方面。目前 ,蛋白质组学研究已应用于膀胱癌、乳腺癌、结肠癌、食管癌。
出处
《国外医学(肿瘤学分册)》
2002年第3期166-168,共3页
Foreign Medical Sciences (Cancer Section)
参考文献16
-
1Le Naour F. Contribution of proteomics to tumor immunology [J]. Proteomics, 2001,1(10):1295-1302.
-
2Bichsel VE, Liotta LA, Petricoin EF 3rd. Cancer proteomics:from biomarker discovery to signal pathway profiling[J]. Cancer J, 2001,7(1):69-78.
-
3Pandey A, Mann M. Proteomics to study genes and genomes[J]. Nature, 2000, 405(6788):837-846.
-
4Banks RE, Dram MJ, Forbes MA, et al. The potential use of/laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings[J]. Ectrophoresis, 1999, 20(4-5):689-700.
-
5Shevchenko A, Loboda A, Shevchenko A, et al. MALDI quadruple time-of-flight mass spectrometry: powerful tool for proteomic research[J]. Anal Chem, 2000, 72(9):2132-2141.
-
6Celis JE, Ostergaard M, Jensen NA, et al. Human and mouse proteomic databases: novel resources in the protein universe [J]. FEBS Lett, 1998, 430(1-2):64-72.
-
7Celis JE, Wolf H, Ostergaard M. Bladder squamous cell carcinoma biomarkers derived from proteomics [J]. Electrophoresis, 2000, 21(11):2115-2121.
-
8Vlahou A, Schellhammer PF, Mendrinos S, et at. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine[J]. Am J Pathol, 2001, 158(4):1491-1502.
-
9Paweletz CP, Liotta LA, Petricoin EF 3rd. New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics[J]. Urology, 2001,57(4 Suppl l ):160-163.
-
10Alaiya AA, Franzen B, Auer G, et al. Cancer proteomics: from identifieation of novel markers to creation of artificial learning models for tumor classification[J]. Electrophoresis, 2000, 21 (6) : 1210-1217.
同被引文献29
-
1Aul C, Giagounidis A, Germing U. Epidemiologieal featuresof myelodysplastic syndromes: results from regional cancersurveys and hospital-based statistics [ J ]. Int J Hematol, 2001, 73(4): 405-10.
-
2Ma X, Does M, Raza A, et al. Myelodysplastic syndromes: incidence and survival in the United States[J]. Cancer. 2007, 109(8): 1536-42.
-
3Nolte F, Hotinann WK. Myelodysplastie syndromes: molecular pathogenesis and genomic changes [ J ]. Ann Hematol, 2008, 87( 10): 777-95.
-
4Mano H. DNA micro-array analysis ofmyelodysplastic syndrome [ J ]. Leuk Lymphoma, 2006, 47(1): 9-14.
-
5Rajcevic U, Niclou SP, Jimenez CR. Proteomics strategies for target identification and biomarker discovery in cancer [J ]. Front Biosci, 2009, 14! 3292-303.
-
6Vardiman JW, Harris NL, Brtnming RD. The World Health Organization (WHO) classification of the myeloid neoplasms [J]. Blood, 2002, 100(7): 2292-302.
-
7Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome [ J ]. Cancer, 2005, 104(4): 788-93.
-
8Hsu HC, Lee YM, Tsai WH, et aL Circulating levels ofthrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome [J]. Ontology, 2002, 63 (1): 64-9.
-
9Alexandrakis MG, Passam FH, Pappa CA, et al. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with hone marrow microvascular density [ J ]. Int J Immunopathol Pharmacol, 2005, 18(2): 287-95.
-
10Pro B, Dang NH. CD26/dipeptidyl peptidase IV and its role in cancer [J]. Histol Histopathol. 2004, 19(4): 1345-51.
引证文献3
-
1钟立业,刘天浩,李扬秋,耿素霞,陆泽生,翁建宇,吴穗晶,罗成伟,杜欣.RAEB型骨髓增生异常综合征患者血清蛋白质组学研究[J].南方医科大学学报,2009,29(9):1799-1801. 被引量:3
-
2钟立业,刘天浩,李扬秋,耿素霞,陆泽生,翁建宇,吴穗晶,罗成伟,杜欣.骨髓增生异常综合征患者血清蛋白质组学特征研究[J].实用医学杂志,2009,25(21):3586-3588. 被引量:4
-
3何洁,万祎,黄卫国,刘瑶,赵洁,谢锦云,梁宋平,苏琦.双向电泳分析二烯丙基二硫诱导HL60细胞分化的蛋白表达差异[J].南华大学学报(医学版),2004,32(2):143-146. 被引量:5
二级引证文献11
-
1何洁,万炜,谭晖,梁宋平,黄卫国,苏琦.DADS诱导HL-60细胞分化的相关蛋白[J].南华大学学报(医学版),2006,34(4):487-489. 被引量:1
-
2何洁,万炜,廖前进,谭晖,周秀田,黄卫国,谢海龙,苏琦.DADS诱导HL-60细胞分化中的信号传导相关蛋白[J].南华大学学报(医学版),2007,35(4):477-480.
-
3何洁,万炜,廖前进,宋颖,谭晖,苏琦,梁宋平,谢景云.DADS诱导人白血病细胞分化中的代谢变化[J].南华大学学报(医学版),2007,35(5):646-649.
-
4唐薇,毛小琴,王伟佳,邱宗荫.人急性早幼粒HL60细胞双向电泳条件的优化[J].第四军医大学学报,2008,29(22):2049-2052. 被引量:1
-
5钟立业,李扬秋.骨髓增生异常综合征遗传学及表观遗传学发病机制的研究进展[J].循证医学,2010,10(4):233-236. 被引量:1
-
6钟立业,耿素霞,杜欣,郑海涛,吴穗晶,李扬秋.RAEB型骨髓增生异常综合征患者DDP10异常表达的研究[J].实用医学杂志,2011,27(9):1562-1564. 被引量:2
-
7秦玲,周莉莉,刘珂,伍星.骨髓增生异常综合征异常克隆分布及与外周血细胞变化的关系[J].中国当代医药,2012,19(23):8-9. 被引量:2
-
8王军强,崔兴,吴波.血液系统疾病的蛋白质组学研究[J].临床合理用药杂志,2014,7(10):192-193.
-
9张洪涛,白瑞.多发性骨髓瘤相关蛋白的研究进展[J].国际输血及血液学杂志,2014,37(6):565-569. 被引量:1
-
10王娟,杨叶宁,秦晶,唐玉娴,李清叶,苏琦,谭晖.二烯丙基二硫下调DJ-1抑制人白血病HL-60细胞增殖及诱导分化[J].中国药理学通报,2015,31(3):416-420. 被引量:1
-
1朱自满,李世拥.结直肠癌循环肿瘤细胞的检测方法及研究进展[J].临床外科杂志,2008,16(2):135-137. 被引量:2
-
2田帅,孟凡义.蛋白质组学相关技术研究策略及其在恶性血液病中的应用[J].国外医学(内科学分册),2005,32(11):461-463.
-
3陈伟杰.直肠癌治疗进展[J].西部中医药,2012,25(7):127-128. 被引量:3
-
4程志海.肝尾状叶附垂叶肝癌1例[J].临床肿瘤学杂志,1997,2(3):29-29.
-
5包已男,姜茹鑫,白姆,李峰.信息技术在结直肠癌患者延续护理中的应用进展[J].中华护理杂志,2017,52(3):280-284. 被引量:56
-
6杜鹃,侯健.多发性骨髓瘤治疗热点问题:第56届美国血液学会年会报道[J].白血病.淋巴瘤,2015,24(1):34-36. 被引量:2
-
7刘平平,李晓明.实体肿瘤干细胞分离鉴定技术的研究进展[J].西南军医,2009,11(3):489-492. 被引量:3
-
8潘宏铭,陈薇.2008年非手术恶性肿瘤患者营养支持治疗指南的解读[J].临床肿瘤学杂志,2009,14(9):844-851. 被引量:17
-
9马爱群.高压怎样治疗[J].医药与保健,1999(5):18-18.
-
10陈加力.白血病的MICM分型[J].中华临床医药杂志(北京),2003,4(23):63-64. 被引量:2